PubRank

M N Ellis

Author PubWeight™ 24.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res 1983 1.69
2 Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J Med Virol 1993 1.35
3 Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother 1985 1.17
4 Virus resistance in clinical practice. J Antimicrob Chemother 1983 1.13
5 In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1991 1.10
6 Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob Agents Chemother 1994 1.08
7 Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir. Antimicrob Agents Chemother 1987 1.02
8 Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation. J Infect Dis 1990 1.02
9 Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice. Antiviral Res 1991 0.95
10 Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigs. Antimicrob Agents Chemother 1985 0.92
11 Feline immunodeficiency virus infection of cats as a model to test the effect of certain in vitro selection pressures on the infectivity and virulence of resultant lentivirus variants. Antiviral Res 1993 0.92
12 Viral resistance, clinical experience. Scand J Infect Dis Suppl 1985 0.91
13 Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: correlation of viral susceptibilities and plasma levels with response to therapy. Diagn Microbiol Infect Dis 1987 0.90
14 Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS. Rev Infect Dis 1989 0.89
15 Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir. Antimicrob Agents Chemother 1992 0.87
16 Extended acyclovir therapy for herpes genitalis: changes in virus sensitivity and strain variation. J Antimicrob Chemother 1986 0.85
17 Induction of acyclovir-resistant mutants of herpes simplex virus type I in athymic nude mice. J Antimicrob Chemother 1986 0.83
18 Studies on interferon induction and interferon sensitivity of avian reoviruses. Avian Dis 1984 0.82
19 Angiogenic potency of nucleotide metabolites: potential role in ischemia-induced vascular growth. J Mol Cell Cardiol 1989 0.82
20 The effect of nicotinamide on microvascular density and thermal injury in rats. J Surg Res 1989 0.80
21 Feline lymphoid tissues engrafted into scid mice maintain morphologic structure and produce feline immunoglobulin. Lab Anim Sci 1994 0.78
22 Clinical and laboratory experience with acyclovir-resistant herpes viruses. J Antimicrob Chemother 1986 0.77
23 Viral tissue tropisms and interferon production in white leghorn chickens infected with two avian reovirus strains. Avian Dis 1983 0.76
24 6-Dimethylamino-9-(beta-D-arabinofuranosyl)-9H-purine: pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys. Antiviral Res 1993 0.76
25 Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice. Antimicrob Agents Chemother 1994 0.76
26 Reduced vaccinal protection of turkey herpesvirus against field strains of Marek's disease herpesvirus. Poult Sci 1981 0.76
27 Serological responses to Mycoplasma synoviae in chickens infected with virulent or avirulent strains of Marek's disease virus. Poult Sci 1981 0.75
28 Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus. Vet Immunol Immunopathol 1995 0.75